Margriet Kwint

Chapter 5 104 13. Brink C, Bernchou U, Bertelsen A, Hansen O, Schytte T, Bentzen SM. Locoregional control of non-small cell lung cancer in relation to automated early assessment of tumor regression on cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2014;89(4):916-23. 14. Jabbour SK, Kim S, Haider SA, Xu X, Wu A, Surakanti S, et al. Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2015;92(3):627-33. 15. Wald P, Mo X, Barney C, Gunderson D, Haglund AK, Bazan J, et al. Prognostic Value of Primary Tumor Volume Changes on kV-CBCT during Definitive Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer. J Thorac Oncol. 2017;12(12):1779-87. 16. Walraven I, Kwint M, Belderbos J. The Additional Prognostic Value of Tumor Volume Changes during Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer. J Thorac Oncol. 2018;13(9):e181-e2. 17. Proust-Lima C, Sene M, Taylor JM, Jacqmin-Gadda H. Joint latent class models for longitudinal and time-to-event data: a review. Stat Methods Med Res. 2014;23(1):74-90. 18. Proust-Lima C, Taylor JM. Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach. Biostatistics. 2009;10(3):535-49. 19. Twisk J, Hoekstra T. Classifying developmental trajectories over time should be done with great caution: a comparison between methods. J Clin Epidemiol. 2012;65(10):1078-87. 20. Walraven I, Mast MR, Hoekstra T, Jansen AP, van der Heijden AA, Rauh SP, et al. Distinct HbA1c trajectories in a type 2 diabetes cohort. Acta Diabetol. 2015;52(2):267-75. 21. Belderbos J, Sonke JJ. State-of-the-art lung cancer radiation therapy. Expert Rev Anticancer Ther. 2009;9(10):1353-63. 22. Wolthaus JW, Schneider C, Sonke JJ, van Herk M, Belderbos JS, Rossi MM, et al. Mid- ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys. 2006;65(5):1560-71. 23. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14(1):52-64. 24. Schwarz M, Alber M, Lebesque JV, Mijnheer BJ, Damen EM. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005;62(2):561-70. 25. Bel A, Vos PH, Rodrigus PT, Creutzberg CL, Visser AG, Stroom JC, et al. High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys. 1996;35(2):321-32. 26. Sarrut D. Deformable registration for image-guided radiation therapy. Z Med Phys. 2006;16(4):285-97. 27. Guckenberger M, Baier K, Richter A, Wilbert J, Flentje M. Evolution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC). Radiat Oncol. 2009;4:68. 28. Mencarelli A, van Kranen SR, Hamming-Vrieze O, van Beek S, Nico Rasch CR, van Herk M, et al. Deformable image registration for adaptive radiation therapy of head and neck cancer: accuracy and precision in the presence of tumor changes. Int J Radiat Oncol Biol Phys. 2014;90(3):680-7.